DarioHealth Corp. (DRIO) 10-Year Financial Performance & Capital Metrics

DRIO • • Industrial / General

HealthcareDiagnostics & ResearchDigital Health & Point-of-Care DiagnosticsDigital Therapeutics & Remote Monitoring

AboutDarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK conditions; Dario's behavioral health solution that optimizes access to evidence-based care; chronic condition management solutions; DarioEngage, a proprietary care management platform; and device-specific disposables test strip cartridges, lancets, and blood glucose monitoring systems. It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and diabetes management programs, including lifestyle changes, healthy eating, advanced tracking, and live coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.Show more

Revenue $27M +32.9%
EBITDA -$50M +1.7%
Net Income -$43M +28.1%
EPS (Diluted) -0.61 +68.4%
Gross Margin 49.06% +66.9%
EBITDA Margin -186.08% +26.0%
Operating Margin -213.55% +22.7%
Net Margin -158.09% +45.9%
ROE -65.68% +23.7%
ROIC -69.11% +10.2%
Debt/Equity 0.42 -17.5%
Interest Coverage -601.50 -590.5%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong 5Y sales CAGR of 29.0%

✗Weaknesses

✗Negative free cash flow
✗Shares diluted 100.0% in last year
✗Trading more than 30% below 52-week high
✗Expensive at 11.4x book value
✗Low asset turnover indicates capital-intensive operations

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y87.26%

5Y29.04%

3Y9.65%

TTM7.29%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM28.43%

EPS CAGR

10Y-

5Y-

3Y-

TTM116.46%

ROCE

10Y Avg-226.25%

5Y Avg-88.57%

3Y Avg-61.4%

Latest-62.04%

Peer Comparison

Digital Therapeutics & Remote Monitoring

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
STIMNeuronetics, Inc.	123.96M	1.81	-1.31	4.96%	-34.27%	-141.91%		2.60
DRIODarioHealth Corp.	82.59M	12.22	-20.03	32.86%	-137.17%	-45.27%		0.42

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	823K	2.8M	5.17M	7.39M	7.56M	7.58M	20.51M	27.66M	20.35M	27.04M
Revenue Growth %	15.14%	2.41%	0.84%	0.43%	0.02%	0%	1.71%	0.35%	-0.26%	0.33%
Cost of Goods Sold+	1.68M	3.36M	3.86M	5.63M	4.96M	5.06M	12.44M	18M	14.37M	13.77M
COGS % of Revenue	2.04%	1.2%	0.75%	0.76%	0.66%	0.67%	0.61%	0.65%	0.71%	0.51%
Gross Profit+	-855K	-561K	1.31M	1.76M	2.6M	2.51M	8.07M	9.65M	5.98M	13.27M
Gross Margin %	-1.04%	-0.2%	0.25%	0.24%	0.34%	0.33%	0.39%	0.35%	0.29%	0.49%
Gross Profit Growth %	0.62%	0.34%	3.34%	0.35%	0.47%	-0.03%	2.21%	0.2%	-0.38%	1.22%
Operating Expenses+	6.84M	10.27M	15.73M	19.45M	20.3M	32.42M	84.56M	66.47M	62.17M	71.01M
OpEx % of Revenue	8.31%	3.66%	3.04%	2.63%	2.69%	4.28%	4.12%	2.4%	3.05%	2.63%
Selling, General & Admin	4.28M	8.12M	12.43M	15.78M	16.61M	27.98M	62.36M	46.82M	41.8M	46.83M
SG&A % of Revenue	5.2%	2.9%	2.4%	2.13%	2.2%	3.69%	3.04%	1.69%	2.05%	1.73%
Research & Development	2.56M	2.15M	3.3M	3.68M	3.69M	4.43M	17.22M	19.65M	20.25M	24.18M
R&D % of Revenue	3.12%	0.77%	0.64%	0.5%	0.49%	0.59%	0.84%	0.71%	0.99%	0.89%
Other Operating Expenses	0	0	0	0	0	0	4.99M	0	128K	0
Operating Income+	-7.7M	-11.1M	-14.42M	-17.69M	-17.7M	-29.9M	-76.49M	-56.81M	-56.19M	-57.74M
Operating Margin %	-9.35%	-3.96%	-2.79%	-2.39%	-2.34%	-3.95%	-3.73%	-2.05%	-2.76%	-2.14%
Operating Income Growth %	0.32%	-0.44%	-0.3%	-0.23%	-0%	-0.69%	-1.56%	0.26%	0.01%	-0.03%
EBITDA+	-7.36M	-10.71M	-14.22M	-17.48M	-17.52M	-29.71M	-72.04M	-52.09M	-51.2M	-50.32M
EBITDA Margin %	-8.95%	-3.82%	-2.75%	-2.36%	-2.32%	-3.92%	-3.51%	-1.88%	-2.52%	-1.86%
EBITDA Growth %	0.32%	-0.46%	-0.33%	-0.23%	-0%	-0.7%	-1.42%	0.28%	0.02%	0.02%
D&A (Non-Cash Add-back)	335K	387K	195K	207K	183K	190K	4.46M	4.72M	4.99M	7.43M
EBIT	-7.7M	-10.83M	-14.42M	-17.69M	-17.7M	-29.9M	-74.47M	-60.31M	-59.36M	-57.74M
Net Interest Income+	-22K	-20K	-171K	-18K	-11K	12K	-40K	-2.18M	1.22M	1.02M
Interest Income	0	0	0	0	16K	61K	44K	506K	1.87M	1.12M
Interest Expense	22K	20K	171K	18K	27K	49K	84K	2.68M	645K	96K
Other Income/Expense	556K	214K	-1.32M	-115K	-31K	458K	-235K	-5.38M	-3.17M	13.14M
Pretax Income+	-7.14M	-10.89M	-15.74M	-17.8M	-17.74M	-29.45M	-76.73M	-62.19M	-59.36M	-44.6M
Pretax Margin %	-8.68%	-3.88%	-3.05%	-2.41%	-2.35%	-3.89%	-3.74%	-2.25%	-2.92%	-1.65%
Income Tax+	0	55K	0	-115K	0	0	32K	4K	64K	-1.85M
Effective Tax Rate %	1%	1%	1%	1%	1%	1%	1%	1%	1%	0.96%
Net Income+	-7.14M	-10.89M	-15.74M	-17.8M	-17.74M	-29.45M	-76.76M	-62.19M	-59.43M	-42.75M
Net Margin %	-8.68%	-3.88%	-3.05%	-2.41%	-2.35%	-3.89%	-3.74%	-2.25%	-2.92%	-1.58%
Net Income Growth %	0.45%	-0.52%	-0.45%	-0.13%	0%	-0.66%	-1.61%	0.19%	0.04%	0.28%
Net Income (Continuing)	-7.14M	-10.89M	-15.74M	-17.8M	-17.74M	-29.45M	-76.76M	-62.19M	-59.43M	-42.75M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	-75.27	-41.85	-32.70	-15.21	-7.84	-5.55	-4.63	-2.63	-1.93	-0.61
EPS Growth %	0.86%	0.44%	0.22%	0.53%	0.48%	0.29%	0.17%	0.43%	0.27%	0.68%
EPS (Basic)	-75.27	-41.85	-32.70	-15.21	-7.84	-5.55	-4.63	-2.63	-1.93	0.61
Diluted Shares Outstanding	94.89K	260.15K	481.41K	1.17M	2.27M	5.96M	16.59M	23.64M	28.37M	67.18M
Basic Shares Outstanding	94.89K	260.15K	481.41K	1.17M	2.27M	5.96M	16.59M	23.64M	28.37M	67.18M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	4.29M	2.94M	6.05M	13.31M	22.91M	34.13M	45.6M	65.52M	47.33M	40.53M
Cash & Short-Term Investments	2.75M	1.32M	3.98M	11M	20.59M	28.59M	36M	49.36M	36.8M	28.46M
Cash Only	2.67M	1.09M	3.72M	11M	20.59M	28.59M	36M	49.36M	36.8M	27.76M
Short-Term Investments	80K	225K	258K	0	0	0	0	0	0	697K
Accounts Receivable	22K	290K	435K	234K	712K	1.7M	1.79M	6.42M	3.64M	5.35M
Days Sales Outstanding	9.76	37.76	30.71	11.55	34.38	82.1	31.78	84.68	65.33	72.24
Inventory	601K	888K	1.18M	1.38M	1.41M	2.29M	6.23M	7.96M	5.06M	4.75M
Days Inventory Outstanding	130.73	96.35	111.99	89.29	104.01	165.31	182.68	161.32	128.59	125.96
Other Current Assets	291K	0	258K	251K	0	187K	0	887K	292K	175K
Total Non-Current Assets+	790K	936K	911K	776K	1.65M	1.28M	55.17M	53.67M	49.06M	78.36M
Property, Plant & Equipment	749K	901K	869K	733K	1.41M	1.07M	989K	1.99M	1.87M	1.77M
Fixed Asset Turnover	1.10x	3.11x	5.95x	10.09x	5.35x	7.05x	20.74x	13.87x	10.91x	15.24x
Goodwill	0	0	0	0	0	0	41.64M	41.64M	41.64M	57.43M
Intangible Assets	0	0	0	0	0	0	12.46M	9.92M	5.4M	18.76M
Long-Term Investments	41K	35K	42K	43K	17K	0	20K	6K	6K	0
Other Non-Current Assets	0	0	0	0	224K	205K	57K	117K	143K	392K
Total Assets+	5.08M	3.87M	6.96M	14.09M	24.57M	35.41M	100.77M	119.19M	96.39M	118.88M
Asset Turnover	0.16x	0.72x	0.74x	0.52x	0.31x	0.21x	0.20x	0.23x	0.21x	0.23x
Asset Growth %	0.65%	-0.24%	0.8%	1.03%	0.74%	0.44%	1.85%	0.18%	-0.19%	0.23%
Total Current Liabilities+	1.69M	2.92M	3.02M	5.16M	5.22M	7.03M	14.38M	19.35M	12.49M	16.64M
Accounts Payable	978K	1.81M	1.85M	2.57M	1.66M	2.48M	5.11M	2.32M	1.13M	3.04M
Days Payables Outstanding	212.74	196.61	175.17	166.91	121.81	178.79	149.85	47.08	28.73	80.7
Short-Term Debt	0	0	0	0	317K	0	266K	8.82M	3.95M	5.45M
Deferred Revenue (Current)	31K	0	0	736K	1000K	1000K	1000K	1000K	997K	1000K
Other Current Liabilities	434K	0	0	880K	887K	880K	4.4M	2.19M	4.07M	0
Current Ratio	2.54x	1.00x	2.01x	2.58x	4.39x	4.85x	3.17x	3.39x	3.79x	2.44x
Quick Ratio	2.18x	0.70x	1.61x	2.31x	4.12x	4.53x	2.74x	2.98x	3.38x	2.15x
Cash Conversion Cycle	-72.25	-62.49	-32.47	-66.07	16.58	68.61	64.6	198.92	165.2	117.51
Total Non-Current Liabilities+	2.61M	7.49M	1K	0	455K	222K	846K	19.84M	25.75M	30.23M
Long-Term Debt	0	0	0	0	0	0	0	18.11M	24.59M	23.47M
Capital Lease Obligations	0	0	0	0	455K	222K	21K	827K	885K	765K
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	2.61M	7.49M	1K	0	0	0	825K	910K	276K	5.99M
Total Liabilities	4.3M	10.41M	3.02M	5.16M	5.67M	7.26M	15.22M	39.19M	38.24M	46.87M
Total Debt+	2.36M	0	0	0	772K	532K	287K	28.05M	29.54M	30.19M
Net Debt	-314K	-1.09M	-3.72M	-11M	-19.81M	-28.06M	-35.71M	-21.31M	-7.26M	2.43M
Debt / Equity	3.03x	-	-	-	0.04x	0.02x	0.00x	0.35x	0.51x	0.42x
Debt / EBITDA	-	-	-	-	-	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Coverage	-349.91x	-555.05x	-84.32x	-982.67x	-655.74x	-610.27x	-910.64x	-21.17x	-87.11x	-601.50x
Total Equity+	777K	-6.54M	3.94M	8.93M	18.89M	28.15M	85.55M	80M	58.14M	72.02M
Equity Growth %	1.31%	-9.42%	1.6%	1.26%	1.12%	0.49%	2.04%	-0.06%	-0.27%	0.24%
Book Value per Share	8.19	-25.14	8.19	7.62	8.34	4.72	5.16	3.38	2.05	1.07
Total Shareholders' Equity	777K	-6.54M	3.94M	8.93M	18.89M	28.15M	85.55M	80M	58.14M	72.02M
Common Stock	5K	6K	7K	8K	0	0	2K	3K	3K	4K
Retained Earnings	-43.35M	-54.96M	-70.96M	-89.25M	-110.14M	-143.25M	-222.01M	-285.85M	-349.36M	-390.34M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-432K	-286K	-477K	-440K	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-6.28M	-8.38M	-10.62M	-11.47M	-15.72M	-17.74M	-50.41M	-47.84M	-30.38M	-38.56M
Operating CF Margin %	-7.63%	-2.99%	-2.05%	-1.55%	-2.08%	-2.34%	-2.46%	-1.73%	-1.49%	-1.43%
Operating CF Growth %	0.27%	-0.33%	-0.27%	-0.08%	-0.37%	-0.13%	-1.84%	0.05%	0.37%	-0.27%
Net Income	-7.14M	-10.89M	-15.74M	-17.8M	-17.74M	-29.45M	-76.76M	-62.19M	-59.43M	-42.75M
Depreciation & Amortization	335K	387K	195K	207K	183K	457K	4.46M	4.72M	4.99M	7.43M
Stock-Based Compensation	1.72M	1.04M	3.82M	3.76M	2.26M	0	24.97M	16.98M	19.7M	15.8M
Deferred Taxes	0	0	0	0	-4.69M	0	0	0	0	0
Other Non-Cash Items	-579K	9K	1.18M	-1K	4.69M	11.1M	-503K	3.56M	288K	-16.57M
Working Capital Changes	-614K	1.07M	-77K	2.37M	-429K	150K	-2.57M	-10.9M	4.07M	-2.47M
Change in Receivables	-649K	-226K	-56K	114K	-504K	-604K	-367K	-5.11M	2.83M	1.6M
Change in Inventory	-366K	-287K	-295K	-193K	-37K	-879K	-2.23M	-1.73M	2.89M	308K
Change in Payables	292K	834K	39K	722K	-918K	824K	1.08M	-2.79M	-1.19M	-496K
Cash from Investing+	-113K	-947K	-219K	6K	-113K	-1.62M	-8.13M	-573K	-547K	-8.93M
Capital Expenditures	-110K	-808K	-195K	-71K	-98K	-118K	-261K	-442K	-584K	-138K
CapEx % of Revenue	0.13%	0.29%	0.04%	0.01%	0.01%	0.02%	0.01%	0.02%	0.03%	0.01%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-6K	6K	-7K	-1K	0	-1.5M	-400K	-131K	0	0
Cash from Financing+	7.61M	7.75M	13.46M	18.74M	25.25M	27.55M	65.77M	61.94M	18.25M	38.53M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	533K	210K	0	0	0	0	889K	0	0	0
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-6.39M	-9.19M	-10.81M	-11.54M	-15.82M	-17.85M	-50.67M	-48.42M	-30.96M	-38.7M
FCF Margin %	-7.76%	-3.28%	-2.09%	-1.56%	-2.09%	-2.36%	-2.47%	-1.75%	-1.52%	-1.43%
FCF Growth %	0.3%	-0.44%	-0.18%	-0.07%	-0.37%	-0.13%	-1.84%	0.04%	0.36%	-0.25%
FCF per Share	-67.31	-35.31	-22.46	-9.86	-6.98	-2.99	-3.05	-2.05	-1.09	-0.58
FCF Conversion (FCF/Net Income)	0.88x	0.77x	0.67x	0.64x	0.89x	0.60x	0.66x	0.77x	0.51x	0.90x
Interest Paid	0	0	0	0	0	0	0	1.88M	4.03M	3.93M
Taxes Paid	0	0	0	0	0	0	0	0	0	0

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-919.18%	-	-399.47%	-276.74%	-127.51%	-125.18%	-135.02%	-75.14%	-86.04%	-65.68%
Return on Invested Capital (ROIC)	-	-	-	-	-	-	-229.81%	-78.52%	-76.92%	-69.11%
Gross Margin	-103.89%	-20.01%	25.36%	23.87%	34.36%	33.17%	39.34%	34.91%	29.4%	49.06%
Net Margin	-867.8%	-388.41%	-304.51%	-240.78%	-234.63%	-388.66%	-374.21%	-224.88%	-292%	-158.09%
Debt / Equity	3.03x	-	-	-	0.04x	0.02x	0.00x	0.35x	0.51x	0.42x
Interest Coverage	-349.91x	-555.05x	-84.32x	-982.67x	-655.74x	-610.27x	-910.64x	-21.17x	-87.11x	-601.50x
FCF Conversion	0.88x	0.77x	0.67x	0.64x	0.89x	0.60x	0.66x	0.77x	0.51x	0.90x
Revenue Growth	1513.73%	240.58%	84.45%	43.02%	2.23%	0.22%	170.76%	34.82%	-26.41%	32.86%

Revenue by Segment

	2019	2020	2021	2022	2023	2024
Service	2.07M	1.81M	-	-	-	20.2M
Service Growth	-	-12.57%	-	-	-	-
Services	-	-	2.72M	17.86M	13.08M	-
Services Growth	-	-	-	556.58%	-26.74%	-
Consumers	-	-	-	11.28M	8.29M	-
Consumers Growth	-	-	-	-	-26.47%	-
Commercial	-	-	-	16.38M	-	-
Commercial Growth	-	-	-	-	-	-
Products	-	-	17.79M	-	-	-
Products Growth	-	-	-	-	-	-
Product	5.49M	5.77M	-	-	-	-
Product Growth	-	5.05%	-	-	-	-
Consumer Products And Other Revenues	4.48M	4.39M	-	-	-	-
Consumer Products And Other Revenues Growth	-	-1.92%	-	-	-	-
Membership	2.93M	3.18M	-	-	-	-
Membership Growth	-	8.67%	-	-	-	-

Frequently Asked Questions

Growth & Financials

DarioHealth Corp. (DRIO) reported $24.7M in revenue for fiscal year 2024.

DarioHealth Corp. (DRIO) grew revenue by 32.9% over the past year. This is strong growth.

DarioHealth Corp. (DRIO) reported a net loss of $33.9M for fiscal year 2024.

Dividend & Returns

DarioHealth Corp. (DRIO) has a return on equity (ROE) of -65.7%. Negative ROE indicates the company is unprofitable.

DarioHealth Corp. (DRIO) had negative free cash flow of $26.9M in fiscal year 2024, likely due to heavy capital investments.

US Stock Screener

...

DarioHealth Corp. (DRIO) 10-Year Financial Performance & Capital Metrics

DRIO • • Industrial / General

HealthcareDiagnostics & ResearchDigital Health & Point-of-Care DiagnosticsDigital Therapeutics & Remote Monitoring

Revenue $27M +32.9%
EBITDA -$50M +1.7%
Net Income -$43M +28.1%
EPS (Diluted) -0.61 +68.4%
Gross Margin 49.06% +66.9%
EBITDA Margin -186.08% +26.0%
Operating Margin -213.55% +22.7%
Net Margin -158.09% +45.9%
ROE -65.68% +23.7%
ROIC -69.11% +10.2%
Debt/Equity 0.42 -17.5%
Interest Coverage -601.50 -590.5%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong 5Y sales CAGR of 29.0%

✗Weaknesses

✗Negative free cash flow
✗Shares diluted 100.0% in last year
✗Trading more than 30% below 52-week high
✗Expensive at 11.4x book value
✗Low asset turnover indicates capital-intensive operations

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y87.26%

5Y29.04%

3Y9.65%

TTM7.29%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM28.43%

EPS CAGR

10Y-

5Y-

3Y-

TTM116.46%

ROCE

10Y Avg-226.25%

5Y Avg-88.57%

3Y Avg-61.4%

Latest-62.04%

Peer Comparison

Digital Therapeutics & Remote Monitoring

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
STIMNeuronetics, Inc.	123.96M	1.81	-1.31	4.96%	-34.27%	-141.91%		2.60
DRIODarioHealth Corp.	82.59M	12.22	-20.03	32.86%	-137.17%	-45.27%		0.42

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	823K	2.8M	5.17M	7.39M	7.56M	7.58M	20.51M	27.66M	20.35M	27.04M
Revenue Growth %	15.14%	2.41%	0.84%	0.43%	0.02%	0%	1.71%	0.35%	-0.26%	0.33%
Cost of Goods Sold+	1.68M	3.36M	3.86M	5.63M	4.96M	5.06M	12.44M	18M	14.37M	13.77M
COGS % of Revenue	2.04%	1.2%	0.75%	0.76%	0.66%	0.67%	0.61%	0.65%	0.71%	0.51%
Gross Profit+	-855K	-561K	1.31M	1.76M	2.6M	2.51M	8.07M	9.65M	5.98M	13.27M
Gross Margin %	-1.04%	-0.2%	0.25%	0.24%	0.34%	0.33%	0.39%	0.35%	0.29%	0.49%
Gross Profit Growth %	0.62%	0.34%	3.34%	0.35%	0.47%	-0.03%	2.21%	0.2%	-0.38%	1.22%
Operating Expenses+	6.84M	10.27M	15.73M	19.45M	20.3M	32.42M	84.56M	66.47M	62.17M	71.01M
OpEx % of Revenue	8.31%	3.66%	3.04%	2.63%	2.69%	4.28%	4.12%	2.4%	3.05%	2.63%
Selling, General & Admin	4.28M	8.12M	12.43M	15.78M	16.61M	27.98M	62.36M	46.82M	41.8M	46.83M
SG&A % of Revenue	5.2%	2.9%	2.4%	2.13%	2.2%	3.69%	3.04%	1.69%	2.05%	1.73%
Research & Development	2.56M	2.15M	3.3M	3.68M	3.69M	4.43M	17.22M	19.65M	20.25M	24.18M
R&D % of Revenue	3.12%	0.77%	0.64%	0.5%	0.49%	0.59%	0.84%	0.71%	0.99%	0.89%
Other Operating Expenses	0	0	0	0	0	0	4.99M	0	128K	0
Operating Income+	-7.7M	-11.1M	-14.42M	-17.69M	-17.7M	-29.9M	-76.49M	-56.81M	-56.19M	-57.74M
Operating Margin %	-9.35%	-3.96%	-2.79%	-2.39%	-2.34%	-3.95%	-3.73%	-2.05%	-2.76%	-2.14%
Operating Income Growth %	0.32%	-0.44%	-0.3%	-0.23%	-0%	-0.69%	-1.56%	0.26%	0.01%	-0.03%
EBITDA+	-7.36M	-10.71M	-14.22M	-17.48M	-17.52M	-29.71M	-72.04M	-52.09M	-51.2M	-50.32M
EBITDA Margin %	-8.95%	-3.82%	-2.75%	-2.36%	-2.32%	-3.92%	-3.51%	-1.88%	-2.52%	-1.86%
EBITDA Growth %	0.32%	-0.46%	-0.33%	-0.23%	-0%	-0.7%	-1.42%	0.28%	0.02%	0.02%
D&A (Non-Cash Add-back)	335K	387K	195K	207K	183K	190K	4.46M	4.72M	4.99M	7.43M
EBIT	-7.7M	-10.83M	-14.42M	-17.69M	-17.7M	-29.9M	-74.47M	-60.31M	-59.36M	-57.74M
Net Interest Income+	-22K	-20K	-171K	-18K	-11K	12K	-40K	-2.18M	1.22M	1.02M
Interest Income	0	0	0	0	16K	61K	44K	506K	1.87M	1.12M
Interest Expense	22K	20K	171K	18K	27K	49K	84K	2.68M	645K	96K
Other Income/Expense	556K	214K	-1.32M	-115K	-31K	458K	-235K	-5.38M	-3.17M	13.14M
Pretax Income+	-7.14M	-10.89M	-15.74M	-17.8M	-17.74M	-29.45M	-76.73M	-62.19M	-59.36M	-44.6M
Pretax Margin %	-8.68%	-3.88%	-3.05%	-2.41%	-2.35%	-3.89%	-3.74%	-2.25%	-2.92%	-1.65%
Income Tax+	0	55K	0	-115K	0	0	32K	4K	64K	-1.85M
Effective Tax Rate %	1%	1%	1%	1%	1%	1%	1%	1%	1%	0.96%
Net Income+	-7.14M	-10.89M	-15.74M	-17.8M	-17.74M	-29.45M	-76.76M	-62.19M	-59.43M	-42.75M
Net Margin %	-8.68%	-3.88%	-3.05%	-2.41%	-2.35%	-3.89%	-3.74%	-2.25%	-2.92%	-1.58%
Net Income Growth %	0.45%	-0.52%	-0.45%	-0.13%	0%	-0.66%	-1.61%	0.19%	0.04%	0.28%
Net Income (Continuing)	-7.14M	-10.89M	-15.74M	-17.8M	-17.74M	-29.45M	-76.76M	-62.19M	-59.43M	-42.75M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	-75.27	-41.85	-32.70	-15.21	-7.84	-5.55	-4.63	-2.63	-1.93	-0.61
EPS Growth %	0.86%	0.44%	0.22%	0.53%	0.48%	0.29%	0.17%	0.43%	0.27%	0.68%
EPS (Basic)	-75.27	-41.85	-32.70	-15.21	-7.84	-5.55	-4.63	-2.63	-1.93	0.61
Diluted Shares Outstanding	94.89K	260.15K	481.41K	1.17M	2.27M	5.96M	16.59M	23.64M	28.37M	67.18M
Basic Shares Outstanding	94.89K	260.15K	481.41K	1.17M	2.27M	5.96M	16.59M	23.64M	28.37M	67.18M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	4.29M	2.94M	6.05M	13.31M	22.91M	34.13M	45.6M	65.52M	47.33M	40.53M
Cash & Short-Term Investments	2.75M	1.32M	3.98M	11M	20.59M	28.59M	36M	49.36M	36.8M	28.46M
Cash Only	2.67M	1.09M	3.72M	11M	20.59M	28.59M	36M	49.36M	36.8M	27.76M
Short-Term Investments	80K	225K	258K	0	0	0	0	0	0	697K
Accounts Receivable	22K	290K	435K	234K	712K	1.7M	1.79M	6.42M	3.64M	5.35M
Days Sales Outstanding	9.76	37.76	30.71	11.55	34.38	82.1	31.78	84.68	65.33	72.24
Inventory	601K	888K	1.18M	1.38M	1.41M	2.29M	6.23M	7.96M	5.06M	4.75M
Days Inventory Outstanding	130.73	96.35	111.99	89.29	104.01	165.31	182.68	161.32	128.59	125.96
Other Current Assets	291K	0	258K	251K	0	187K	0	887K	292K	175K
Total Non-Current Assets+	790K	936K	911K	776K	1.65M	1.28M	55.17M	53.67M	49.06M	78.36M
Property, Plant & Equipment	749K	901K	869K	733K	1.41M	1.07M	989K	1.99M	1.87M	1.77M
Fixed Asset Turnover	1.10x	3.11x	5.95x	10.09x	5.35x	7.05x	20.74x	13.87x	10.91x	15.24x
Goodwill	0	0	0	0	0	0	41.64M	41.64M	41.64M	57.43M
Intangible Assets	0	0	0	0	0	0	12.46M	9.92M	5.4M	18.76M
Long-Term Investments	41K	35K	42K	43K	17K	0	20K	6K	6K	0
Other Non-Current Assets	0	0	0	0	224K	205K	57K	117K	143K	392K
Total Assets+	5.08M	3.87M	6.96M	14.09M	24.57M	35.41M	100.77M	119.19M	96.39M	118.88M
Asset Turnover	0.16x	0.72x	0.74x	0.52x	0.31x	0.21x	0.20x	0.23x	0.21x	0.23x
Asset Growth %	0.65%	-0.24%	0.8%	1.03%	0.74%	0.44%	1.85%	0.18%	-0.19%	0.23%
Total Current Liabilities+	1.69M	2.92M	3.02M	5.16M	5.22M	7.03M	14.38M	19.35M	12.49M	16.64M
Accounts Payable	978K	1.81M	1.85M	2.57M	1.66M	2.48M	5.11M	2.32M	1.13M	3.04M
Days Payables Outstanding	212.74	196.61	175.17	166.91	121.81	178.79	149.85	47.08	28.73	80.7
Short-Term Debt	0	0	0	0	317K	0	266K	8.82M	3.95M	5.45M
Deferred Revenue (Current)	31K	0	0	736K	1000K	1000K	1000K	1000K	997K	1000K
Other Current Liabilities	434K	0	0	880K	887K	880K	4.4M	2.19M	4.07M	0
Current Ratio	2.54x	1.00x	2.01x	2.58x	4.39x	4.85x	3.17x	3.39x	3.79x	2.44x
Quick Ratio	2.18x	0.70x	1.61x	2.31x	4.12x	4.53x	2.74x	2.98x	3.38x	2.15x
Cash Conversion Cycle	-72.25	-62.49	-32.47	-66.07	16.58	68.61	64.6	198.92	165.2	117.51
Total Non-Current Liabilities+	2.61M	7.49M	1K	0	455K	222K	846K	19.84M	25.75M	30.23M
Long-Term Debt	0	0	0	0	0	0	0	18.11M	24.59M	23.47M
Capital Lease Obligations	0	0	0	0	455K	222K	21K	827K	885K	765K
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	2.61M	7.49M	1K	0	0	0	825K	910K	276K	5.99M
Total Liabilities	4.3M	10.41M	3.02M	5.16M	5.67M	7.26M	15.22M	39.19M	38.24M	46.87M
Total Debt+	2.36M	0	0	0	772K	532K	287K	28.05M	29.54M	30.19M
Net Debt	-314K	-1.09M	-3.72M	-11M	-19.81M	-28.06M	-35.71M	-21.31M	-7.26M	2.43M
Debt / Equity	3.03x	-	-	-	0.04x	0.02x	0.00x	0.35x	0.51x	0.42x
Debt / EBITDA	-	-	-	-	-	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Coverage	-349.91x	-555.05x	-84.32x	-982.67x	-655.74x	-610.27x	-910.64x	-21.17x	-87.11x	-601.50x
Total Equity+	777K	-6.54M	3.94M	8.93M	18.89M	28.15M	85.55M	80M	58.14M	72.02M
Equity Growth %	1.31%	-9.42%	1.6%	1.26%	1.12%	0.49%	2.04%	-0.06%	-0.27%	0.24%
Book Value per Share	8.19	-25.14	8.19	7.62	8.34	4.72	5.16	3.38	2.05	1.07
Total Shareholders' Equity	777K	-6.54M	3.94M	8.93M	18.89M	28.15M	85.55M	80M	58.14M	72.02M
Common Stock	5K	6K	7K	8K	0	0	2K	3K	3K	4K
Retained Earnings	-43.35M	-54.96M	-70.96M	-89.25M	-110.14M	-143.25M	-222.01M	-285.85M	-349.36M	-390.34M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-432K	-286K	-477K	-440K	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-6.28M	-8.38M	-10.62M	-11.47M	-15.72M	-17.74M	-50.41M	-47.84M	-30.38M	-38.56M
Operating CF Margin %	-7.63%	-2.99%	-2.05%	-1.55%	-2.08%	-2.34%	-2.46%	-1.73%	-1.49%	-1.43%
Operating CF Growth %	0.27%	-0.33%	-0.27%	-0.08%	-0.37%	-0.13%	-1.84%	0.05%	0.37%	-0.27%
Net Income	-7.14M	-10.89M	-15.74M	-17.8M	-17.74M	-29.45M	-76.76M	-62.19M	-59.43M	-42.75M
Depreciation & Amortization	335K	387K	195K	207K	183K	457K	4.46M	4.72M	4.99M	7.43M
Stock-Based Compensation	1.72M	1.04M	3.82M	3.76M	2.26M	0	24.97M	16.98M	19.7M	15.8M
Deferred Taxes	0	0	0	0	-4.69M	0	0	0	0	0
Other Non-Cash Items	-579K	9K	1.18M	-1K	4.69M	11.1M	-503K	3.56M	288K	-16.57M
Working Capital Changes	-614K	1.07M	-77K	2.37M	-429K	150K	-2.57M	-10.9M	4.07M	-2.47M
Change in Receivables	-649K	-226K	-56K	114K	-504K	-604K	-367K	-5.11M	2.83M	1.6M
Change in Inventory	-366K	-287K	-295K	-193K	-37K	-879K	-2.23M	-1.73M	2.89M	308K
Change in Payables	292K	834K	39K	722K	-918K	824K	1.08M	-2.79M	-1.19M	-496K
Cash from Investing+	-113K	-947K	-219K	6K	-113K	-1.62M	-8.13M	-573K	-547K	-8.93M
Capital Expenditures	-110K	-808K	-195K	-71K	-98K	-118K	-261K	-442K	-584K	-138K
CapEx % of Revenue	0.13%	0.29%	0.04%	0.01%	0.01%	0.02%	0.01%	0.02%	0.03%	0.01%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-6K	6K	-7K	-1K	0	-1.5M	-400K	-131K	0	0
Cash from Financing+	7.61M	7.75M	13.46M	18.74M	25.25M	27.55M	65.77M	61.94M	18.25M	38.53M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	533K	210K	0	0	0	0	889K	0	0	0
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-6.39M	-9.19M	-10.81M	-11.54M	-15.82M	-17.85M	-50.67M	-48.42M	-30.96M	-38.7M
FCF Margin %	-7.76%	-3.28%	-2.09%	-1.56%	-2.09%	-2.36%	-2.47%	-1.75%	-1.52%	-1.43%
FCF Growth %	0.3%	-0.44%	-0.18%	-0.07%	-0.37%	-0.13%	-1.84%	0.04%	0.36%	-0.25%
FCF per Share	-67.31	-35.31	-22.46	-9.86	-6.98	-2.99	-3.05	-2.05	-1.09	-0.58
FCF Conversion (FCF/Net Income)	0.88x	0.77x	0.67x	0.64x	0.89x	0.60x	0.66x	0.77x	0.51x	0.90x
Interest Paid	0	0	0	0	0	0	0	1.88M	4.03M	3.93M
Taxes Paid	0	0	0	0	0	0	0	0	0	0

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-919.18%	-	-399.47%	-276.74%	-127.51%	-125.18%	-135.02%	-75.14%	-86.04%	-65.68%
Return on Invested Capital (ROIC)	-	-	-	-	-	-	-229.81%	-78.52%	-76.92%	-69.11%
Gross Margin	-103.89%	-20.01%	25.36%	23.87%	34.36%	33.17%	39.34%	34.91%	29.4%	49.06%
Net Margin	-867.8%	-388.41%	-304.51%	-240.78%	-234.63%	-388.66%	-374.21%	-224.88%	-292%	-158.09%
Debt / Equity	3.03x	-	-	-	0.04x	0.02x	0.00x	0.35x	0.51x	0.42x
Interest Coverage	-349.91x	-555.05x	-84.32x	-982.67x	-655.74x	-610.27x	-910.64x	-21.17x	-87.11x	-601.50x
FCF Conversion	0.88x	0.77x	0.67x	0.64x	0.89x	0.60x	0.66x	0.77x	0.51x	0.90x
Revenue Growth	1513.73%	240.58%	84.45%	43.02%	2.23%	0.22%	170.76%	34.82%	-26.41%	32.86%

Revenue by Segment

	2019	2020	2021	2022	2023	2024
Service	2.07M	1.81M	-	-	-	20.2M
Service Growth	-	-12.57%	-	-	-	-
Services	-	-	2.72M	17.86M	13.08M	-
Services Growth	-	-	-	556.58%	-26.74%	-
Consumers	-	-	-	11.28M	8.29M	-
Consumers Growth	-	-	-	-	-26.47%	-
Commercial	-	-	-	16.38M	-	-
Commercial Growth	-	-	-	-	-	-
Products	-	-	17.79M	-	-	-
Products Growth	-	-	-	-	-	-
Product	5.49M	5.77M	-	-	-	-
Product Growth	-	5.05%	-	-	-	-
Consumer Products And Other Revenues	4.48M	4.39M	-	-	-	-
Consumer Products And Other Revenues Growth	-	-1.92%	-	-	-	-
Membership	2.93M	3.18M	-	-	-	-
Membership Growth	-	8.67%	-	-	-	-

Frequently Asked Questions

Growth & Financials

DarioHealth Corp. (DRIO) reported $24.7M in revenue for fiscal year 2024.

DarioHealth Corp. (DRIO) grew revenue by 32.9% over the past year. This is strong growth.

DarioHealth Corp. (DRIO) reported a net loss of $33.9M for fiscal year 2024.

Dividend & Returns

DarioHealth Corp. (DRIO) has a return on equity (ROE) of -65.7%. Negative ROE indicates the company is unprofitable.

DarioHealth Corp. (DRIO) had negative free cash flow of $26.9M in fiscal year 2024, likely due to heavy capital investments.